Combined Evaluation of Epigenetic and Sensitising Therapy in AML and MDS

Clinical trial NCT05636514 · RECRUITING

Trial details

NCT number: NCT05636514
Sponsor: Clinical Hub for Interventional Research (CHOIR)
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia Acute Myeloid Leukemia

Start date: 2022-12-14
Primary completion: 2026-08-30
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.